II
CRL icon

IFM Investors’s Charles River Laboratories CRL Stock Holding History

IFM Investors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,630
Closed -$1.59M – 660
2024
Q4 		$1.59M Sell
8,630
-755
-8% -$145K 0.02% 540
2024
Q3 		$1.85M Sell
9,385
-275
-3% -$57.1K 0.02% 539
2024
Q2 		$2M Buy
9,660
+74
+0.8% +$16.8K 0.02% 522
2024
Q1 		$2.6M Buy
+9,586
New +$2.29M 0.03% 478
2023
Q4 		– Sell
-8,963
Closed -$1.76M – 586
2023
Q3 		$1.76M Buy
8,963
+797
+10% +$164K 0.02% 531
2023
Q2 		$1.72M Buy
8,166
+213
+3% +$42.4K 0.02% 530
2023
Q1 		$1.61M Buy
7,953
+34
+0.4% +$7.71K 0.02% 530
2022
Q4 		$1.73M Sell
7,919
-178
-2% -$38.9K 0.03% 503
2022
Q3 		$1.59M Buy
8,097
+519
+7% +$112K 0.03% 503
2022
Q2 		$1.62M Hold
7,578
– – 0.03% 506
2022
Q1 		$2.15M Buy
7,578
+1,310
+21% +$404K 0.03% 478
2021
Q4 		$2.36M Hold
6,268
– – 0.04% 409
2021
Q3 		$2.59M Buy
6,268
+35
+0.6% +$14.5K 0.05% 360
2021
Q2 		$2.31M Buy
+6,233
New +$2.08M 0.05% 417

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

IFM Investors's CRL Position: Q1 2025 in Review

IFM Investors sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 8,630 shares — an estimated $1.59M sold.

IFM Investors first reported a position in CRL in Q2 2021 and held it in 14 quarters. The position peaked at $2.6M in Q1 2024. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • IFM Investors reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • IFM Investors sold 8,630 Charles River Laboratories shares in Q1 2025, an estimated $1.59M.
  • IFM Investors first reported a position in Charles River Laboratories in Q2 2021 and held it in 14 quarters.
  • IFM Investors's Charles River Laboratories position peaked at $2.6M in Q1 2024.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on IFM Investors's 13F filing for Q1 2025, filed 29 Apr 2025.